Japan Tumor Ablation Market Size & Outlook, 2023-2030
Japan tumor ablation market, 2018-2030 (US$M)
Related Markets
Japan tumor ablation market highlights
- The Japan tumor ablation market generated a revenue of USD 110.9 million in 2023 and is expected to reach USD 283.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 14.3% from 2024 to 2030.
- In terms of segment, radiofrequency ablation was the largest revenue generating technology in 2023.
- Irreversible Electroporation is the most lucrative technology segment registering the fastest growth during the forecast period.
Tumor ablation market data book summary
| Market revenue in 2023 | USD 110.9 million |
| Market revenue in 2030 | USD 283.1 million |
| Growth rate | 14.3% (CAGR from 2023 to 2030) |
| Largest segment | Radiofrequency ablation |
| Fastest growing segment | Irreversible Electroporation |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
| Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
Other key industry trends
- In terms of revenue, Japan accounted for 6.6% of the global tumor ablation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan tumor ablation market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 230.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Ablation Market Scope
Tumor Ablation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan tumor ablation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.45% in 2023. Horizon Databook has segmented the Japan tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, increasing prevalence of cancer, rising government initiatives for better healthcare infrastructure, benefits associated with tumor ablation, and presence of major market players in the country are among the factors expected to propel market growth.
In June 2023, a research article published by the researchers at the Kindai University Faculty of Medicine stated that in 2019, there were 13,380 cases of ovarian cancer, 17,880 cases of uterus-related cancer, and 10,879 cases of cervix-related cancer.
The occurrence of ovarian cancer has tripled, the frequency of uterine corpus cancer (primarily endometrial cancer) has surged by 15 times, the mortality rate of uterine corpus cancer has tripled, and the prevalence of cervical intraepithelial cancer has risen tenfold.
Reasons to subscribe to Japan tumor ablation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan tumor ablation market databook
-
Our clientele includes a mix of tumor ablation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into Japan tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan tumor ablation market size, by technology, 2018-2030 (US$M)
Japan Tumor Ablation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
